Three-Dimensional Cell Culture Based on Magnetic Fields to Assemble Low-Grade Ovarian Carcinoma Cell Aggregates Containing Lymphocytes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE
    • Publication Information:
      Original Publication: Basel, Switzerland : MDPI
    • Subject Terms:
      Cell Aggregation/*immunology ; Cell Culture Techniques/*methods ; Lymphocytes/*pathology ; Ovarian Neoplasms/*blood; Cell Line, Tumor ; Female ; Humans ; Magnetic Fields ; Neoplasm Grading ; Ovarian Neoplasms/physiopathology ; Tumor Microenvironment
    • Abstract:
      There is a limited number of established ovarian cancer cell lines matching the low-grade serous histotype available for research purposes. Three-dimensional (3D) culture systems provide in vitro models with better tissue-like characteristics than two-dimensional (2D) systems. The goal in the study was to characterize the growth of a given low-grade serous ovarian carcinoma cell line in a 3D culture system conducted in a magnetic field. Moreover, the culture system was evaluated in respect to the assembly of malignant cell aggregates containing lymphocytes. CAISMOV24 cell line alone or mixed with human peripheral blood mononuclear cells (PBMC) were cultured using a commercially available 3D culture system designed for 24 well plates. Resulting cell aggregates revealed the intrinsic capacity of CAISMOV24 cells to assemble structures morphologically defined as papillary, and reflected molecular characteristics usually found in ovarian carcinomas. The contents of lymphocytes into co-cultured cell aggregates were significantly higher ( p < 0.05) when NanoShuttle-conjugated PBMC were employed compared with non-conjugated PBMC. Moreover, lymphocyte subsets NK, T-CD4, T-CD8 and T-regulatory were successfully retrieved from co-cultured cell aggregates at 72h. Thus, the culture system allowed CAISMOV24 cell line to develop papillary-like cell aggregates containing lymphocytes.
    • References:
      Nat Commun. 2017 Sep 12;8(1):400. (PMID: 28900152)
      J Exp Med. 2005 Oct 17;202(8):1075-85. (PMID: 16230475)
      J Ovarian Res. 2014 Jun 07;7:60. (PMID: 24936210)
      Int J Cancer. 2015 Mar 1;136(5):E359-86. (PMID: 25220842)
      Am J Surg Pathol. 2016 Sep;40(9):1165-76. (PMID: 27487741)
      Bioelectromagnetics. 2010 Dec;31(8):649-55. (PMID: 20830734)
      Cytokine Growth Factor Rev. 2002 Apr;13(2):169-83. (PMID: 11900992)
      Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1357-8. (PMID: 22307585)
      PLoS One. 2014 Jun 02;9(6):e97897. (PMID: 24887420)
      Oncotarget. 2016 May 3;7(18):25930-48. (PMID: 27036018)
      Am J Pathol. 2016 Apr;186(4):733-47. (PMID: 27012190)
      Adv Drug Deliv Rev. 2014 Dec 15;79-80:193-213. (PMID: 24969478)
      Nat Rev Cancer. 2005 May;5(5):355-66. (PMID: 15864277)
      Oncotarget. 2018 Apr 24;9(31):21893-21903. (PMID: 29774110)
      Mol Pharm. 2014 Jul 7;11(7):2182-9. (PMID: 24842574)
      J Immunol Methods. 2015 Nov;426:1-13. (PMID: 26215372)
      Gynecol Oncol. 2012 Feb;124(2):192-8. (PMID: 22040834)
      Am J Pathol. 2001 Dec;159(6):2071-80. (PMID: 11733357)
      BMC Cancer. 2017 Nov 13;17(1):756. (PMID: 29132324)
      Semin Cancer Biol. 2005 Oct;15(5):365-77. (PMID: 15975824)
      Ecancermedicalscience. 2014 Sep 25;8:465. (PMID: 25371706)
      Tissue Eng Part C Methods. 2013 Sep;19(9):665-75. (PMID: 23301612)
      Methods Mol Biol. 2013;1049:323-36. (PMID: 23913227)
      Biotechnol J. 2011 Feb;6(2):204-212. (PMID: 21298805)
      J Biosci Bioeng. 2014 Aug;118(2):214-22. (PMID: 24684961)
      BMC Cell Biol. 2013 Sep 27;14:43. (PMID: 24070420)
      Sci Adv. 2019 Jan 30;5(1):eaau7201. (PMID: 30729158)
      Cell. 2007 Aug 24;130(4):601-10. (PMID: 17719539)
      Nat Protoc. 2013 Oct;8(10):1940-9. (PMID: 24030442)
      Immunol Cell Biol. 2014 Mar;92(3):210-3. (PMID: 24492800)
      Nat Med. 2019 May;25(5):838-849. (PMID: 31011202)
      Adv Drug Deliv Rev. 2014 Dec 15;79-80:145-54. (PMID: 24819215)
      Cancer Sci. 2016 Sep;107(9):1173-8. (PMID: 27297561)
      Nat Med. 2004 Sep;10(9):942-9. (PMID: 15322536)
      Nat Commun. 2013;4:2126. (PMID: 23839242)
      Neoplasma. 2013;60(5):546-52. (PMID: 23790174)
      Cancer Sci. 2016 Dec;107(12):1858-1866. (PMID: 27699918)
      Cytopathology. 2004 Jun;15(3):131-41. (PMID: 15165269)
      Clin Dev Immunol. 2010;2010:791603. (PMID: 21318181)
      Adv Drug Deliv Rev. 2014 Dec 15;79-80:184-92. (PMID: 25034878)
      Cancer Res. 2012 Jun 1;72(11):2701-4. (PMID: 22593197)
      Cancer Res. 1977 Oct;37(10):3639-43. (PMID: 908012)
      Rev Bras Ginecol Obstet. 2012 May;34(5):196-202. (PMID: 22584853)
      Neoplasia. 2015 Jan;17(1):1-15. (PMID: 25622895)
      Nature. 2019 Jan;565(7738):E5-E6. (PMID: 30559381)
      Am J Surg Pathol. 2016 May;40(5):627-35. (PMID: 26900814)
      Int J Mol Sci. 2017 May 17;18(5):. (PMID: 28513532)
      CA Cancer J Clin. 2017 Jan;67(1):7-30. (PMID: 28055103)
      Lab Invest. 2013 May;93(5):528-42. (PMID: 23459371)
      Cancer Immunol Immunother. 2015 Mar;64(3):337-47. (PMID: 25416072)
      Am J Cancer Res. 2016 Oct 01;6(10):2235-2251. (PMID: 27822414)
    • Contributed Indexing:
      Keywords: 3D culture; CAISMOV24 cell line; cell aggregate; tumor microenvironment
    • Publication Date:
      Date Created: 20200312 Date Completed: 20210311 Latest Revision: 20210311
    • Publication Date:
      20231215
    • Accession Number:
      PMC7140502
    • Accession Number:
      10.3390/cells9030635
    • Accession Number:
      32155738